CompletedNCT04189835
EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients
Studying Epstein-Barr virus-associated malignant lymphoproliferative disorder
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Aarhus
- Principal Investigator
- Bente Jespersen, ProfessorAarhus University Hospital
- Intervention
- EBV DNA in whole blood and plasma(diagnostic_test)
- Enrollment
- 509 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2020 – 2024
Study locations (3)
- Aarhus University Hospital, Aarhus, Central Region Denmark, Denmark
- Odense University Hospital, Odense, Region Syddanmark, Denmark
- Rikshospitalet, Oslo Universitetssykehus, Oslo, Norway
Collaborators
Rikshospitalet University Hospital · Aarhus University Hospital · Odense University Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04189835 on ClinicalTrials.govOther trials for Epstein-Barr virus-associated malignant lymphoproliferative disorder
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07381738Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative DisordersFudan University
- RECRUITINGPHASE1, PHASE2NCT07450391EBV-AST Cell Injection for EBV-Associated Lymphoproliferative DisordersDaihong Liu
See all trials for Epstein-Barr virus-associated malignant lymphoproliferative disorder →